Durdević S, Visnjevac V, Kermeci K
Klinicki centar, Novi Sad.
Med Pregl. 2001 Sep-Oct;54(9-10):465-9.
Wertheim from Vienna was the first to introduce the technique of radical hysterectomy into surgical practice in treatment of uterine cervix carcinoma associated with partial lymphadenectomy (1989). In concern to the level of surgical extensiveness, radical hysterectomy can be divided into 5 classes (after Piver-Rutledge).
At the Department of Obstetrics and Gynaecology in Novi Sad 55 patients with invasive cervical cancer (FIGO st. IB1-IIB) underwent surgery during the period from 1991 to 2001. All patients underwent radical hysterectomy after Wertheim-Meigs technique. The aim of this study was to present operative techniques of radical hysterectomy and complications following surgery.
Distribution by stage of the disease was as follows: IB1 = 39 (70.9%), IB2 = 6 (10.9%), IIA = 7 (12.7%) and IIB = 3 (5.5%). On average, there were 15 lymph nodes removed, out of which 9 (16.4%) cases were positive. Postoperative complications were recorded in 19 (34.5%) patients, whereas the incidence of urinary fistulas and intrahospital mortality rate have been reduced to the minimum (0%). Recurrence was evident in 3 (5.4%) patients and 5-year survival rate was 92.3% (in patients operated up to 1997).
In relation to previously published results of treatment at the Department, there is an evident increase in the number of stage I patients and a decrease in stage II patients, as well as a reduced incidence of postoperative urinary fistulas, total number of complications, but an increase in the 5-year survival rate.
来自维也纳的韦特海姆是首个将根治性子宫切除术技术引入外科实践以治疗子宫颈癌并进行部分淋巴结清扫术的人(1989年)。就手术范围而言,根治性子宫切除术可分为5类(根据皮弗-拉特利奇分类法)。
在诺维萨德的妇产科,1991年至2001年期间,55例浸润性宫颈癌患者(国际妇产科联盟分期为IB1-IIB期)接受了手术。所有患者均采用韦特海姆-梅格斯技术进行根治性子宫切除术。本研究的目的是介绍根治性子宫切除术的手术技术及术后并发症。
疾病分期分布如下:IB1期=39例(70.9%),IB2期=6例(10.9%),IIA期=7例(12.7%),IIB期=3例(5.5%)。平均切除15个淋巴结,其中9例(16.4%)为阳性。19例(34.5%)患者记录到术后并发症,而尿瘘发生率和院内死亡率已降至最低(0%)。3例(5.4%)患者出现复发,5年生存率为92.3%(1997年之前接受手术的患者)。
与该科室先前公布的治疗结果相比,I期患者数量明显增加,II期患者数量减少,术后尿瘘发生率、并发症总数降低,但5年生存率有所提高。